Homozygous familial hypercholesterolaemia in two boys aged 5 and 10 years

Paediatr Int Child Health. 2016 Nov;36(4):308-311. doi: 10.1080/20469047.2016.1188497. Epub 2016 Jul 4.

Abstract

Familial hypercholesterolaemia (FH) is an autosomal dominant lipid disorder. Homozygous FH (HFH), though rare, presents in early childhood. Two different presentations of HFH are reported. The first child presented at 5 years of age with xanthomas on the knees, elbows and buttocks and failure to thrive since the second year of life. He was found to be hypertensive with moderate aortic regurgitation. He is now stable on statins and antihypertensives. The second child presented at 10 years of age with multiple xanthomas and severe aortic stenosis. He died of refractory cardiac failure despite emergency aortic balloon valvoplasty due to diffuse coronary artery disease. Strong clinical suspicion can aid early diagnosis and delay cardiovascular complications.

Keywords: Familial; Homozygous; Hypercholesterolaemia; Low-density level cholesterol.

Publication types

  • Case Reports

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Aortic Diseases / etiology*
  • Aortic Diseases / pathology*
  • Aortic Diseases / surgery
  • Balloon Valvuloplasty
  • Child
  • Child, Preschool
  • Fatal Outcome
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipoproteinemia Type II / diagnosis*
  • Hyperlipoproteinemia Type II / drug therapy
  • Hyperlipoproteinemia Type II / pathology*
  • Male
  • Xanthomatosis / etiology*
  • Xanthomatosis / pathology*

Substances

  • Antihypertensive Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors